With the latest funds, private equity firm Petra has $14 million invested in Nashville-based SpecialtyCare, which is led by former Renal Care Group executive Gary Brukardt.
— GETAHN WARD
Nodality Inc. raises $15.5M in financing
Nodality Inc., a San Francisco-based biotechnology company with a research and development laboratory in Franklin, said it has raised $15.5 million in a new round of financing.
Pfizer Ventures, an arm of Pfizer Inc., and Laboratory Corp. of America Holdings led the round. Other participants included Kleiner Perkins Caulfield & Byers, TPG Biotechnology and Maverick Capital, which like Pfizer previously had invested in Nodality.
Nodality focuses on developing the next generation of personalized medical tests for cancer and autoimmune disease treatments.
— GETAHN WARD
Nonresidential Construction Industry Continues to StruggleTake Part: Has your medical identity been stolen?
